Skip to main content

Month: June 2021

BankFinancial Corporation Expands Share Repurchase Program

BURR RIDGE, Ill., June 24, 2021 (GLOBE NEWSWIRE) — The Board of Directors of BankFinancial Corporation (the “Company”) increased the total number of shares currently authorized for repurchase under the Share Repurchase Program by 900,000 shares. As of June 24, 2021, a total of 99,661 shares remained authorized for purchase pursuant to the previous share repurchase authorization. Therefore, as of June 24, 2021, the total number of shares authorized for repurchase is 999,661. The share repurchase authorization remains in effect through November 15, 2021. The authorization permits shares to be repurchased in open market or negotiated transactions, and pursuant to any trading plan that may be adopted in accordance with Rule 10b5-1 of the Securities and Exchange Commission. The authorization will be utilized at management’s...

Continue reading

Adial Pharmaceuticals Provides Regulatory and Development Update

CHARLOTTESVILLE, Va., June 24, 2021 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced that it has received correspondence related to its request for Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its drug candidate, AD04, for the treatment of Alcohol Use Disorder (AUD) in pediatric patients and adult patients with Alcoholic Liver Disease (ALD) with select polymorphisms of the serotonin transporter and receptor genes. While AD04 is being developed and undergoing a pivotal Phase 3 trial to treat any adult with AUD with the targeted genetics, Adial believes AD04 holds the potential to effectively and safely treat AUD patients that are adolescents or have ALD. The Company...

Continue reading

DIRTT Expands Litigation Against Falkbuilt in Texas and Seeks Order Compelling Smed and Loberg to Attend Depositions in Canada

CALGARY, Alberta, June 24, 2021 (GLOBE NEWSWIRE) — DIRTT Environmental Solutions Ltd. (“DIRTT”) (TSX: DRT, NASDAQ: DRTT) an interior construction company that uses proprietary software to design, manufacture and install fully customizable environments, announces that it has expanded its litigation against Falkbuilt (a company started by two of DIRTT’s founders Mogens Smed and Barrie Loberg), and continues to aggressively pursue Smed, Loberg and Falkbuilt via four separate lawsuits across North America, as outlined below. Kevin O’Meara, chief executive officer, stated, “Our primary focus is the successful execution of our strategic plan and capturing the benefits of improving construction market conditions, however we also remain steadfast in our commitment to vigorously defend the value of our business, our brand and the interests...

Continue reading

Field Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year 2021 Financial Results

Field Trip completes FY2021 as the largest vertically integrated psychedelics company positioned to be a leader in the emerging industryContinues to leverage its early mover opportunity by investing in its drug development strategy and the build out of a globally recognized brand of psychedelic-assisted therapy centers Closed FY2021 with $111,817,443 in unrestricted cash and cash equivalents, funds held in trust and short-term investments after successfully completing two bought deal offerings for gross proceeds of $115 million Development of FT-104, a novel psychedelic molecule with pending patents, continues to progress with GMP production underway in preparation for Phase 1 studies 6 Field Trip Health centers have commenced operations and are in early stages of ramp up to break-even; Q4 2021 patient services revenues grew by 66%...

Continue reading

Mainframe Expands into 2D Series Production

WOW!’s Mainframe Studios Diversifies Storytelling Capabilities VANCOUVER, Canada, June 24, 2021 (GLOBE NEWSWIRE) — Mainframe Studios, a division of WOW! Unlimited Media Inc. (“WOW!” or the “Company”) (TSXV: WOW; OTCQX: WOWMF), expands the diversity of their content with a dedicated 2D Pipeline. The award-winning CG animation studio is elevating their creative roster with a newly appointed team of 2D animation storytellers. Already a leader in the 3D animation space, Mainframe’s constant drive to innovate has resulted in shows that incorporate live action and Epic’s real-time Unreal engine. Branching into 2D production furthers the studio’s range of creative approach for both original IP and service projects. Mainframe’s original IP The Guava Juice Show, a YouTube Originals, is the studio’s first 2D animation series out of the gate...

Continue reading

Purpose Investments Inc. Announces 2021 Second Quarter Distributions for Purpose Specialty Lending Trust

TORONTO, June 24, 2021 (GLOBE NEWSWIRE) — Purpose Investments Inc. is pleased to announce the 2021 second quarter distributions for Purpose Specialty Lending Trust.  Ticker Symbol Distributionper share/unit Ex Distribution Date Record Date Payable DatePurpose Specialty Lending Trust – Class A Unlisted $0.1160 06/29/2021 06/30/2021 07/23/2021Purpose Specialty Lending Trust – Class F Unlisted $0.1200 06/29/2021 06/30/2021 07/23/2021Purpose Specialty Lending Trust – Class U Unlisted US$ 0.1425 06/29/2021 06/30/2021 07/23/2021Purpose Specialty Lending Trust – Class A1, Series 2 Unlisted $0.1350 06/29/2021 06/30/2021 07/23/2021Purpose Specialty Lending Trust – Class F, Series 3 Unlisted $0.1400 06/29/2021 06/30/2021 07/23/2021About Purpose Investments Inc. Purpose Investments Inc. is an asset management company...

Continue reading

Bioventus Invests in Vaporox

Ultrasonic Technology to Heal Diabetic Foot Ulcers DURHAM, N.C., June 24, 2021 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has completed a minority investment in Vaporox, Inc., a developer of a highly innovative diabetic foot ulcer (“DFU”) wound healing therapy. Founded in 2016, Vaporox is based in Denver, Colorado and has developed a patented, ultrasonic technology, Vaporous Hyperoxia Therapy™ (“VHT”), that has demonstrated the ability to heal approximately 85% of DFUs that were unresponsive to the current standard of care. DFUs represent a tremendous cost to the health care system and are one of the most common and severe complications associated with diabetes. Foot and ankle surgeons are the leading specialty treating the over two million...

Continue reading

CTO Realty Growth Announces the Acquisition of the Shops at Legacy in the Plano Submarket of Dallas, Texas for $72.5 Million

DAYTONA BEACH, Fla., June 24, 2021 (GLOBE NEWSWIRE) — CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) today announced it has acquired The Shops at Legacy North, an approximately 236,000 square foot retail-driven mixed-use lifestyle property in Plano, Texas (the “Property”). The Shops at Legacy North, which was constructed in 2007 and includes nearly 1,000 parking spaces, is currently 83% occupied and is situated on 12.7 acres across the Dallas North Tollway from Legacy West at the core of the 2,665-acre master-planned Legacy District, one of the premier live-work-play communities in the United States. The Property has excellent accessibility to a large concentration of Fortune 500 Companies, is surrounded by approximately 8,000 apartment units and nearly 2,500 hotel rooms, and benefits from excellent demographics with...

Continue reading

ARMOUR Residential REIT, Inc. Announces Guidance for July 2021 Dividend Rate Per Common Share

VERO BEACH, Florida, June 24, 2021 (GLOBE NEWSWIRE) — ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) (“ARMOUR” or the “Company”) today announced guidance on the July 2021 cash dividend for the Company’s Common Stock, which maintains the current monthly dividend rate of $0.10 per Common share. July 2021 Common Stock Dividend InformationMonth   Dividend   Holder of Record Date   Payment DateJuly 2021   $0.10   July 15, 2021   July 29, 2021Certain Tax Matters ARMOUR has elected to be taxed as a real estate investment trust (“REIT”) for U.S. Federal income tax purposes. In order to maintain this tax status, ARMOUR is required to timely distribute substantially all of its ordinary REIT taxable income. Dividends paid in excess of current tax earnings and profits for the year will generally not be taxable to common...

Continue reading

Progress Announces Second Quarter 2021 Financial Results

Q2 Revenue and Earnings Per Share Exceed Guidance Full Year Guidance Raised BEDFORD, Mass., June 24, 2021 (GLOBE NEWSWIRE) — Progress (NASDAQ: PRGS), the leading provider of products to develop, deploy and manage high-impact business applications, today announced financial results for its fiscal second quarter ended May 31, 2021. Second Quarter 2021 Highlights:Revenue of $122.5 million increased 22% year-over-year on an actual currency basis, and 19% on a constant currency basis. Non-GAAP revenue of $129.2 million increased 26% on an actual currency basis, and 23% on a constant currency basis. Annualized Recurring Revenue (ARR) of $437 million increased 23% year-over-year on a constant currency basis. Operating margin was 18% and Non-GAAP operating margin was 38%. Diluted earnings per share was $0.30 compared to $0.37 in the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.